3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Liver Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pain
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Melanoma
1
Malignant Pleural Neoplasm
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Leiomyoma
1
Ileus
1
Hordeolum
1
Glioblastoma
1
Eyelid Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Paclitaxel
6
pembrolizumab
3
Cisplatin
3
Carboplatin
3
Biopsy
3
adavosertib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Doxorubicin
2
ulixertinib
1
tucatinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
sacituzumab govitecan
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
niraparib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Lidocaine
×
1 year
×
Clear all
No trials found.